Whole-body MRI scans help predict myeloma relapse and improve patient monitoring
The Institute of Cancer Research (ICR) - 04-Aug-2025Doctors can now tailor treatments more precisely with these insights
Join the club for FREE to access the whole archive and other member benefits.
Doctors can now tailor treatments more precisely with these insights
The project supports better early detection and new treatments worldwide
Non-invasive brain scans may soon help track focus, memory, and cognitive health over time
New MRI-based tech may better detect tumour changes without contrast dye in brain cancer patients
New patch collects molecular data without cutting tissue, enabling faster, safer disease diagnosis
Researchers link gut metabolite imbalances to short-term mortality in critically ill patients
Genetic traces of cancer may be detectable in blood up to three years before diagnosis, study finds
It may help patients start treatment earlier or join clinical trials
Researchers uncover how unhealthy lifestyles can accelerate heart ageing
A groundbreaking metagenomics test identified a rare bacteria after five years of failed diagnose
Tracks glucose, activity, and sleep—offering a simpler option for people with Type 2 diabetes
Experts urge caution over routine scans due to long-term radiation risks
Troponin testing could help doctors catch heart risks earlier and save lives
UK study shows AI speeds up 20-week scans and boosts accuracy and care
The robot takes detailed 3D scans without needing surgery
This could lead to better long-term health monitoring and disease management
Innovative wearable tracks sleep patterns with precision, making at-home diagnosis easier than ever
These stable, customizable sensors enable remote health monitoring
Full-body scans drive early detection as Neko expands globally
It offers a faster, less invasive way to improve early diagnosis
The new method uses radiotracers to make cancer cells visible
Developed with Oxford BioDynamics, EpiSwitch PSE cuts false positives to reduce unnecessary biopsies
Clinical trials have begun on patients with severe kidney disease
It can identify brain conditions like bleeds and changes in small blood vessels
Breakthrough technology measures protein changes to monitor and prevent disease